Lumosa Therapeutics Co., Ltd.
Taipei Exchange 6535.TWO
Lumosa Therapeutics Co., Ltd. Dividend Yield on January 14, 2025: 0.00%
Lumosa Therapeutics Co., Ltd. Dividend Yield is 0.00% on January 14, 2025, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
-
Lumosa Therapeutics Co., Ltd. 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
-
Lumosa Therapeutics Co., Ltd. 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
-
Lumosa Therapeutics Co., Ltd. average Dividend Yield for the last 52 weeks is 0.00%.
Key data
| Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
|---|
Market news
Loading...
Taipei Exchange: 6535.TWO
| CEO | Li Fang Pan |
| IPO Date | July 16, 2015 |
| Location | |
| Headquarters | No. 3-2, Park Street |
| Employees | 47 |
| Sector | Health Care |
| Industries | |
Description
Lumosa Therapeutics Co., Ltd., a clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan. The company offers LT - 1001, an analgesic injection that has completed Phase III clinical trials for severe pain relief after surgery. It is also developing LT3001, which is in Phase II clinical trial for the treatment of acute ischemic stroke; LT5001 that has completed Phase Ib clinical trial for uremic pruritus; and LT2003, which is in pre-clinical stage for the treatment of oncology. Lumosa Therapeutics Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email